CAS 2756-87-8
:Monomethyl fumarate
- (2E)-4-methoxy-4-oxobut-2-enoic acid
- (2Z)-4-methoxy-4-oxobut-2-enoic acid
- (E)-4-Methoxy-4-oxo-but-2-enoic acid
- (E)-4-Methoxy-4-oxobut-2-enoic acid
- 2-Butenedioic acid (2E)-, 1-methyl ester
- 2-Butenedioic acid (2E)-, monomethyl ester
- 2-Butenedioic acid (E)-, monomethyl ester
- Fumaric acid monomethyl ester
- Fumaric acid, methyl ester
- Methyl hydrogen fumarate
Monomethyl Fumarate
CAS:Formula:C5H6O4Purity:>98.0%(GC)Color and Shape:White to Almost white powder to crystalMolecular weight:130.10Dimethyl Fumarate Related Compound A ((E)-4-Methoxy-4-oxobut-2-enoic acid)
CAS:Acyclic polycarboxylic acids and their anhydrides, halides, peroxides and their derivatives, nesoiFormula:C5H6O4Color and Shape:White PowderMolecular weight:130.026612-Butenedioic acid (2E)-, 1-methyl ester
CAS:Formula:C5H6O4Purity:95%Color and Shape:SolidMolecular weight:130.0987Monomethyl fumarate
CAS:Monomethyl fumarate is a potent agonist of GPR109A .Formula:C5H6O4Purity:99.21%Color and Shape:SolidMolecular weight:130.1mono-Methyl fumarate
CAS:mono-Methyl fumarateFormula:C5H6O4Purity:98%Color and Shape: white solidMolecular weight:130.10g/molDimethyl Fumarate USP Related Compound A (Monomethyl Fumarate)
CAS:Formula:C5H6O4Color and Shape:White To Off-White SolidMolecular weight:130.10mono-Methyl fumarate
CAS:Formula:C5H6O4Purity:≥ 97%Color and Shape:White to off-white powder or solidMolecular weight:130.10Dimethyl Fumarate USP Related Compound A (Monomethyl Fumarate)
CAS:Controlled ProductFormula:C5H6O4Color and Shape:NeatMolecular weight:130.10Fumaric Acid Monomethyl Ester
CAS:Controlled ProductApplications Fumaric Acid Monomethyl Ester is one of the most bioactive anti-psoriatic fumaric acid ester metabolite. Fumaric acid monomethyl ester is potent nicotinic acid receptor agonist. Fumaric acid monomethyl ester has also been shown to selectively stimulate of T helper 2 cytokine response. It is also the active metabolite of Dimethyl Fumarate (D464965), a compound that is used as a treatment for the relapsing forms of multiple sclerosis and psoriasis.
References de Jong, R. et al.: Eur. J. Immunol., 26, 2067 (1996); Litjens, N.H.R. et al.: Br. J. Dermatol., 154, 211 (2006); Schimrigk, S., et al.: Eur. J. Neurol., 13, 604 (2006); Tang, H. et al.: Biochem. Biophys. Res. Comm., 375, 562 (2008)Formula:C5H6O4Color and Shape:NeatMolecular weight:130.1Monomethyl fumarate
CAS:Monomethyl fumarate is a metabolite of dimethyl fumarate (DMF) and has been shown to be an inhibitor of the mitochondrial membrane potential. DMF is currently in clinical trials for the treatment of bowel disease, but its use has been limited by its poor oral bioavailability. Monomethyl fumarate has been shown to be more potent than DMF in inhibiting mitochondrial membrane potential and, therefore, may be a better therapeutic candidate for the treatment of bowel disease. Monomethyl fumarate also inhibits cell lysis through inhibition of tiglic acid production and increased resistance to autoimmune diseases.
Formula:C5H6O4Purity:Min. 98 Area-%Color and Shape:White Off-White PowderMolecular weight:130.1 g/mol












